Zepbound may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, and worsening of diabetic retinopathy if you have type 2 diabetes
Key Research Areas and Use Cases This combination has attracted research interest across several areas: GH axis modulation studies examining how dual-pathway stimulation compares to single-agent protocols Age-related endocrine research studying natural GH decline patterns in aging models Body composition research investigating lean mass and fat metabolism markers in animal and cellular models Sleep and recovery studies some research has explored GH pulse timing and sleep architecture Metabolic research investigating insulin sensitivity and lipid markers under GH-stimulated conditions Important: None of the above represents a clinical claim
& Cortet, B
These include: Medullary thyroid carcinoma (MTC): Retatrutide is contraindicated in individuals with personal or family history of thyroid cancer, such as medullary thyroid cancer or Multiple endocrine neoplasia syndrome type 2 (MEN 2), because this medication can increase the risk of thyroid C-cell tumors
Pricing reflects bundled care including physician-supervised medical care, treatment management, ongoing clinical support, and compounded medication when prescribed
Plus our Multiple-Injection pack is more affordable than buying the same in single drips
